Clinical Research Directory
Browse clinical research sites, groups, and studies.
Observational Study of VYKAT™ XR in Patients With Prader-Willi Syndrome
Sponsor: Soleno Therapeutics, Inc.
Summary
Prospective observational study developed to generate more evidence of the safety profile, clinical characteristics and outcomes of patients with PWS treated with VYKAT XR.
Official title: An Observational Study of VYKAT™ XR (Diazoxide Choline Extended-Release Tablets) in Patients With Prader-Willi Syndrome (PWS)
Key Details
Gender
All
Age Range
4 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2025-11-26
Completion Date
2028-03-02
Last Updated
2026-08-21
Healthy Volunteers
No
Conditions
Interventions
VYKAT XR
All prospective treatment in this protocol will be commercial VYKAT XR prescribed to patients by their physicians in addition to their standard of care; patients will not receive experimental intervention or treatment from the Sponsor as part of their participation in this study.
Locations (24)
Neurocrine Clinical Site
Phoenix, Arizona, United States
Neurocrine Clinical Site
Los Angeles, California, United States
Neurocrine Clinical Site
Sacramento, California, United States
Neurocrine Clinical Site
Aurora, Colorado, United States
Neurocrine Clinical Site
Atlanta, Georgia, United States
Neurocrine Clinical Site
Chicago, Illinois, United States
Neurocrine Clinical Site
Indianapolis, Indiana, United States
Neurocrine Clinical Site
Boston, Massachusetts, United States
Neurocrine Clinical Site
Ann Arbor, Michigan, United States
Neurocrine Clinical Site
Lansing, Michigan, United States
Neurocrine Clinical Site
Minneapolis, Minnesota, United States
Neurocrine Clinical Site
Rochester, Minnesota, United States
Neurocrine Clinical Site
Saint Paul, Minnesota, United States
Neurocrine Clinical Site
Kansas City, Missouri, United States
Neurocrine Clinical Site
Paterson, New Jersey, United States
Neurocrine Clinical Site
Valley Stream, New York, United States
Neurocrine Clinical Site
Chapel Hill, North Carolina, United States
Neurocrine Clinical Site
Durham, North Carolina, United States
Neurocrine Clinical Site
Portland, Oregon, United States
Neurocrine Clinical Site
Nashville, Tennessee, United States
Neurocrine Clinical Site
Dallas, Texas, United States
Neurocrine Clinical Site
Houston, Texas, United States
Neurocrine Clinical Site
Salt Lake City, Utah, United States
Neurocrine Clinical Site
Seattle, Washington, United States